See today's BioWorld Science
To read the full story, subscribe or sign in.
Immuno-oncology

Antengene’s anti-CD24 antibody ATG-031 cleared by FDA to enter clinic for solid tumors and B-NHL

May 18, 2023
Antengene Corp. Ltd. has received FDA clearance of its IND for a phase I study of the first-in-class...
BioWorld Science Cancer Immuno-oncology Monoclonal antibody FDA IND